Go to body Contents
Tacrolimus

CERES F&D Tacrolimus Immunosuppressant

  • Payment
    T/T
  • MOQ
    1 ea
  • Supply Ability
    1,000,000 ea per One-Time
  • Supply Details
    Sample Order

    Depend on quantity

  • Country of sale
    Americas, Asia, Europe, Middle East, World Wide
  • PRICE
    • FOB

      USD 10.00 ~ 1,000.00

      (1 ea)

Trade Assurance Service

ITEM SPECIFICS

  • Brand
    Tacrolimus
    Model Tacrolimus
  • origin
    Republic of Korea
  • Size(Capacity)
    .
  • Function
    Immunosuppresant
  • Material
    Chemical Powder
  • Color
    White
  • Style
    3 years
  • Condition
    Powder
Tacrolimus
White Powder made in South Korea, Suitable for each Pharmacopoeia (USP, JP, IP, Ph.Eur)
Purpose
Immunosuppressant
Effects/Benefits
Primarily used to reduce the risk of organ rejection in patients with allogeneic organ transplantation. It is also used to treat autoimmune diseases, such as atopic dermatitis.
Main functions
Tacrolimus is a polyketide macrolide lactone with immunosuppressive activity.
Primary advantages
Tacrolimus is a highly potent immunosuppressant. Compared to a similar immunosuppressant cyclosporine, tacrolimus has been shown to be 10 to 100 times more potent and have less side effects, such as hypertension, hirsutism and gingivalhyperplasia.
Competitiveness
Since 2003, Ceres F&D has researched industrial technologies for microbial bioactive substances biological active substance to develop high-production fermentations strains for industrial production of tacrolimus (patent no. 2007-0082624), high-purity processes suitable for pharmaceutical standards (patent no. 2008-00915, 2008-0091521), genetic biosynthesis of tacrolimus (patent no. 2008-00118854), and analysis methods of tacrolimus and its related substances. Based on these patented technologies, in 2009, we registered and scaled up from lab scale to plant scale for commercial production of tacrolimus.
Instruction
For pharmaceutical preparation and manufacture only If there is an example of a single system, refer to the single system 'Cautions for Use'.
Storage and Handling Precautions
1. Carefully store on temperature, sunlight, humidity, and others.
2. Put in the original container and keep it closed. (Taking out of the original container and store in another container may cause an accident caused by misuse or deterioration of the medication quality).
Company Profile
Biopharmaceutical company producing immunosuppressants and antibiotics

Factory Information
Located in Jecheon-si, South Korea, our manufacturing site is cGMP certified and operates according to the highest production and quality standards. With separate production lines for immunosuppressants and antibiotics, our facilities are designed to maximize efficiency and quality while minimizing risk.
 
Other Products

R&D CERTIFICATE

  • KGMP 
    MFDS(Minisry of Food and Drug Safety ) 
    2013.03.08 
    인증서보기

PAYMENTS DETAILS

This supplier supports payments for offline orders
  • Telegraphic Transfer : T/T
Contact Payment Manager
  • Name : Eunjung Yoo
  • Tel : 82-436528404
  • Email : ejyoo16@ceresfnd.com

SHIPPING

Shipping from : Republic of Korea
  • 100 Bio valley 2-ro, Jecheon-si, Chungcheongbuk-do (27159)
CERES F&D Co., Ltd.
  • The person in charge

    JAE MIN SON
  • Telephone

    82-436528404
  • Fax

    82-436528406
  • Address

    100 Bio valley 2-ro, Jecheon-si, Chungcheongbuk-do (27159)

세레스에프엔디

CERES F&D Co., Ltd.
Introduction
Solution for Biologics & Fermentations Ceres F&D biopharmaceutical company producing immunosuppressants and antibiotics. At Ceres F&D, we are committed to developing high-quality biosimilars and producing innovative solutions that are more effective than conventional pharmaceuticals. Business Our focus is on producing Tacrolimus, Vancomycin, and Teicoplanin. We are currently manufacturing immunosuppressants, manufacturing/selling antibiotics, researching antibody-antibiotic conjugates, cultivating microbes, and studying manufacturing techniques.
  • Business Type :
    Manufacturer
  • Main Product :
    Tacrolimus, Hyaluronidase
  • Established :
    2018-06-15
  • Total Annual Revenue :
  • Total Employees :
    5~10 people

R&D CERTIFICATE

  • KGMP 
    MFDS(Minisry of Food and Drug Safety ) 
    2013.03.08 
    인증서보기

CUSTOMER QUESTIONS & ANSWERS

0 / 4000

질문이 없습니다.

CUSTOMER REVIEWS (0)

At least 10~1000 characters.

0/ 1000

COMPARISON TO SIMILAR ITEMS more

  • No Items
supplier level
MEMBER
CERES F&D Co., Ltd. Seller's Store
Seller's Store url
  • Response Level
      41% ~ 50%
  • Supplier Level
      Less than 100 million (KRW)
  • Transaction Level
      less than 5
SUPPLIER BEST
  • CERES F&D Teicoplanin Antibiotics